Journal of Substance Use
Overview
Journal of Substance Use is a scientific journal, published by Informa Healthcare since 1999 in English. The journal's country of origin is United Kingdom.
Details
Details
Abbr.
J Subst Use
Publisher
Informa Healthcare
Start
1999
End
Continuing
Frequency
Quarterly
p-ISSN
1465-9891
Country
United Kingdom
Language
English
Metrics
Metrics
h-index / Ranks: 9569
35
SJR / Ranks: 11898
297
CiteScore / Ranks: 11545
1.60
Recent Articles
1.
Frankeberger J, Coulter R, Mair C
J Subst Use
. 2024 Dec;
29(5):753-758.
PMID: 39649387
Background: Research on alcohol-related problems often examines individual problem types in isolation or uses scales that provide a single cumulative severity score for alcohol-related harms. This study aims to assess...
2.
Gormley M, Zhang W, Self S, Ewing J, Heo M, Roth P, et al.
J Subst Use
. 2024 Nov;
29(5):836-842.
PMID: 39502837
Background: Treating hepatitis C virus (HCV) in people who inject drugs (PWID) has been associated with increased health-related quality of life (HRQOL). Polysubstance use (PSU) is common among PWID, but...
3.
Kolp H, Horvath S, Fite P, Metrik J, Stuart G, Lisdahl K, et al.
J Subst Use
. 2024 Sep;
29(4):509-516.
PMID: 39268332
Background: Despite the prevalence and negative outcomes associated with simultaneous alcohol and cannabis use (i.e., marijuana [SAM] use; i.e., so that the effects of both alcohol and cannabis overlap) among...
4.
Cho J, Sussman S, Kechter A, Vogel E, Barrington-Trimis J, Unger J, et al.
J Subst Use
. 2024 Jul;
29(4):554-561.
PMID: 39055691
Objective: To estimate the extent to which drinking to cope with the COVID-19 pandemic and experiencing pandemic-related life stressors are associated with alcohol use escalation among young adults. Methods: Respondents...
5.
Gorman J, Lindvig-Springborn A, Lee J, Khazanov G, DePhilippis D
J Subst Use
. 2024 Jul;
2024:1-6.
PMID: 39055109
Background And Objectives: Contingency management (CM) for substance use disorders (SUD) is effective in strengthening recovery behaviors, however can be quite burdensome. When health facilities experience staff shortages, adapting current...
6.
Brezing C, Sibai M, Choi C, Mitra S, Mariani J, Naqvi N, et al.
J Subst Use
. 2024 Jul;
29(4):487-494.
PMID: 39021751
Background And Objective: Cannabis Use Disorder (CUD) has no FDA approved treatment. Serotonin-2c (5HT2c) agonists have preclinical and human laboratory evidence for potential efficacy for CUD. We assessed the tolerability...
7.
Tofighi B, Lopez R, Araujo G, Lee J, Samuels E, Wightman R, et al.
J Subst Use
. 2024 Jul;
29(3):347-353.
PMID: 39005537
Introduction: This mixed-methods study assessed buprenorphine provider and administrator perceptions and experiences in offering telebuprenorphine during the COVID-19 pandemic. Methods: Semi-structured interviews were conducted between June 2021 and September 2021...
8.
9.
Rainey J, Satcher L, Nechuta S
J Subst Use
. 2024 May;
28(5):789-796.
PMID: 38751610
Background: Neonatal abstinence syndrome (NAS), largely a consequence of prenatal opioid exposure, results in substantial morbidity. Population-based studies of NAS going beyond Medicaid populations and hospital discharge data (HDD) alone...
10.
Hayes B, Favaro J, Behrends C, Coello D, Jakubowski A, Fox A
J Subst Use
. 2024 Apr;
29(1):129-135.
PMID: 38577252
Background: Despite proven health benefits, harm reduction services provided through in-person syringe services programs (SSPs) and pharmacies are largely unavailable to most people who inject drugs (PWID). Internet-based mail-delivered harm...